These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37767359)

  • 1. Transfer of maternal immunity using a polyvalent vaccine and offspring protection in Nile tilapia,
    Amrullah A; Wahidah W; Ardiansyah A; Indrayani I
    F1000Res; 2021; 10():966. PubMed ID: 37767359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-protective efficiency of feed-based whole-cell inactivated bivalent vaccine against Streptococcus and Aeromonas infections in red hybrid tilapia (Oreochromis niloticus × Oreochromis mossambicus).
    Monir MS; Yusoff MSM; Zulperi ZM; Hassim HA; Zamri-Saad M; Amal MNA; Salleh A; Mohamad A; Yie LJ; Ina-Salwany MY
    Fish Shellfish Immunol; 2021 Jun; 113():162-175. PubMed ID: 33857622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemato-immunological responses and effectiveness of feed-based bivalent vaccine against Streptococcus iniae and Aeromonas hydrophila infections in hybrid red tilapia (Oreochromis mossambicus × O. niloticus).
    Monir MS; Yusoff SBM; Zulperi ZBM; Hassim HBA; Mohamad A; Ngoo MSBMH; Ina-Salwany MY
    BMC Vet Res; 2020 Jul; 16(1):226. PubMed ID: 32615969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Injectable and Immersion Polyvalent Vaccine against Streptococcal Infections in Broodstock and Offspring of Nile tilapia (Oreochromis niloticus).
    Abu-Elala NM; Samir A; Wasfy M; Elsayed M
    Fish Shellfish Immunol; 2019 May; 88():293-300. PubMed ID: 30807857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Streptococcus agalactiae concentration on immune system and effective dose of inactivated vaccine for Chitralada 3 strain Nile tilapia (Oreochromis niloticus) in Thailand.
    Khunrang T; Pooljun C; Wuthisuthimethavee S
    BMC Vet Res; 2023 Dec; 19(1):267. PubMed ID: 38082432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-immunity in Nile tilapia vaccinated with Streptococcus agalactiae and Streptococcus iniae vaccines.
    Wang Q; Fu T; Li X; Luo Q; Huang J; Sun Y; Wang X
    Fish Shellfish Immunol; 2020 Feb; 97():382-389. PubMed ID: 31841691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response and protective efficacy of two new adjuvants, Montanide™ ISA 763B VG and Montanide™ GEL02, administered with a Streptococcus agalactiae ghost vaccine in Nile tilapia (Oreochromis niloticus).
    Wangkaghart E; Deville S; Wang B; Srisapoome P; Wang T; Secombes CJ
    Fish Shellfish Immunol; 2021 Sep; 116():19-29. PubMed ID: 34153428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the effects of Montanide™ ISA 763A VG and ISA 763B VG adjuvants on the immune response against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus).
    Wangkahart E; Thongsrisuk A; Vialle R; Pholchamat S; Sunthamala P; Phudkliang J; Srisapoome P; Wang T; Secombes CJ
    Fish Shellfish Immunol; 2023 Mar; 134():108563. PubMed ID: 36717067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral delivery of a Streptococcus agalactiae vaccine to Nile tilapia (Oreochromis niloticus) using a novel cationic-based nanoemulsion containing bile salts.
    Suwanbumrung D; Wongkhieo S; Keaswejjareansuk W; Dechbumroong P; Kamble MT; Yata T; Kitiyodom S; Rodkhum C; Thompson KD; Namdee K; Pirarat N
    Fish Shellfish Immunol; 2023 Aug; 139():108913. PubMed ID: 37393062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy of MONTANIDE™ GR01, a new adjuvant for feed-based vaccines, on the immune response and protection against Streptococcus agalactiae in oral vaccinated Nile tilapia (Oreochromis niloticus) under laboratory and on-farm conditions.
    Pholchamat S; Vialle R; Luang-In V; Phadee P; Wang B; Wang T; Secombes CJ; Wangkahart E
    Fish Shellfish Immunol; 2024 Jun; 149():109567. PubMed ID: 38641215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of live attenuated Streptococcus agalactiae as potential vaccines by selecting for resistance to sparfloxacin.
    Pridgeon JW; Klesius PH
    Vaccine; 2013 May; 31(24):2705-12. PubMed ID: 23583891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of Protection and Humoral Immune Response in Nile Tilapia (
    Queiróz GA; Silva TMFE; Leal CAG
    Animals (Basel); 2024 Jun; 14(12):. PubMed ID: 38929363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of live attenuated vaccine derived from the Streptococcus agalactiae on the immune responses of Oreochromis niloticus.
    Laith AA; Abdullah MA; Nurhafizah WWI; Hussein HA; Aya J; Effendy AWM; Najiah M
    Fish Shellfish Immunol; 2019 Jul; 90():235-243. PubMed ID: 31009810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration.
    Evans JJ; Klesius PH; Shoemaker CA
    Vaccine; 2004 Sep; 22(27-28):3769-73. PubMed ID: 15315858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GapA, a potential vaccine candidate antigen against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus).
    Zhang Z; Yu A; Lan J; Zhang H; Hu M; Cheng J; Zhao L; Lin L; Wei S
    Fish Shellfish Immunol; 2017 Apr; 63():255-260. PubMed ID: 28219739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacillus velezensis LF01: in vitro antimicrobial activity against fish pathogens, growth performance enhancement, and disease resistance against streptococcosis in Nile tilapia (Oreochromis niloticus).
    Zhang D; Gao Y; Ke X; Yi M; Liu Z; Han X; Shi C; Lu M
    Appl Microbiol Biotechnol; 2019 Nov; 103(21-22):9023-9035. PubMed ID: 31654082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An effective live attenuated vaccine against Streptococcus agalactiae infection in farmed Nile tilapia (Oreochromis niloticus).
    Zhang D; Gao Y; Li Q; Ke X; Liu Z; Lu M; Shi C
    Fish Shellfish Immunol; 2020 Mar; 98():853-859. PubMed ID: 31751658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of novel antigenic vaccine candidates for nile tilapia (Oreochromis niloticus) against Streptococcus agalactiae infection.
    Ma Y; Hao L; Liang Z; Ma J; Ke H; Kang H; Yang H; Wu J; Feng G; Liu Z
    Fish Shellfish Immunol; 2020 Oct; 105():405-414. PubMed ID: 32712231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of protective antibodies and correlation with survival in Nile tilapia Oreochromis niloticus following Streptococcus agalactiae vaccination.
    Pasnik DJ; Evans JJ; Klesius PH
    Dis Aquat Organ; 2005 Sep; 66(2):129-34. PubMed ID: 16231638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of two adjuvants administrated with a novel hydrogen peroxide-inactivated vaccine against Streptococcus agalactiae in Nile tilapia fingerlings.
    Ramos-Espinoza FC; Cueva-Quiroz VA; Yunis-Aguinaga J; Alvarez-Rubio NC; Paganoti de Mello N; Engrácia de Moraes JR
    Fish Shellfish Immunol; 2020 Oct; 105():350-358. PubMed ID: 32717322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.